Effects of chronic angiotensin I-converting enzyme inhibition on the relations between ventricular action potential changes and myocardial hypertrophy in aging rats

Journal of Cardiovascular Pharmacology
P KreherJ Verdetti


We studied the effect of aging on cardiac hypertrophy and action potential duration (APD) in normotensive male WAG/Rij rats and evaluated the role of the renin-angiotensin system (RAS) in these effects. Cardiac hypertrophy occurs in 30-month-old rats, as indicated by an increase in heart weight, and APD gradually increases with aging in the epicardial region of the right and the left ventricle. Short-term treatment (1 month) with the angiotensin-converting enzyme inhibitor (ACEI) perindopril prevented age-related increase in heart weight/body weight ratio independent of its antihypertensive effects, but did not prevent changes in APD in 30-month-old rats. Our results show a dissociation of changes in cardiac mass from changes in APD during aging. The effect of ACEI on hypertrophy may be due in part to a direct angiotensin effect on cellular growth. Changes in APD are not related to hypertrophy but rather to the process of aging.


Mar 14, 1998·Proceedings of the National Academy of Sciences of the United States of America·B CormanB I Levy
Dec 17, 2014·Journal of Molecular and Cellular Cardiology·Hirad A FeridooniSusan E Howlett
Aug 17, 2004·Journal of Cardiovascular Pharmacology and Therapeutics·Sanjeev WassonMary L Dohrmann
Sep 26, 2003·Journal of Cardiovascular Pharmacology·Kurt W SaupeCarl S Apstein

❮ Previous
Next ❯

Related Concepts

Related Feeds


Cardiomegaly, known as an enlarged heart, is a multifactorial disease with different pathophysiological mechanisms. Hypertension, pregnancy, exercise-induced and idiopathic causes are some mechanisms of cardiomegaly. Discover the latest research of cardiomegaly here.